Physician profile
Stuart A Linder
NPI 1699811455
$14,483.41
in general payments reported to CMS, 2019-2025
9 companies · $3,563 in 2025
The $3,563 reported for 2025 was more than what 90% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,988 · 2020: $284 · 2021: $1,179 · 2022: $1,081 · 2023: $2,430 · 2024: $1,960 · 2025: $3,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,125 · Travel and Lodging: $2,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,124.66 |
| Travel and Lodging | $2,827.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $5,554.90 | 2019-2022 | |
| Tela Bio, INC. | $4,265.98 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $2,157.74 | 2023-2025 | |
| Mentor Worldwide LLC | $1,320.34 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $478.07 | 2020-2021 | |
| Innocoll Pharmaceuticals Limited | $188.54 | 2022-2023 | Xaracoll |
| Becton, Dickinson and Company | $185.83 | 2025 | Galaflex, Phasix Mesh |
| Rti Surgical, INC | $176.61 | 2025 | |
| Davol INC. | $155.40 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Linder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.